![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3
4 Subtype
Departments of Pharmacology (S.C.H., Y.X., R.P.Y., B.B.W., K.J.K.) and Physiology & Biophysics (S.V.), Georgetown University School of Medicine, Washington, DC; and Department of Pharmacology, Howard University College of Medicine, Washington, DC (M.I.D.-G.)
The rat pineal gland contains a high density of neuronal nicotinic acetylcholine receptors (nAChRs). We characterized the pharmacology of the binding sites and function of these receptors, measured the nAChR subunit mRNA, and used subunit-specific antibodies to establish the receptor subtype as defined by subunit composition. In ligand binding studies, [3H]epibatidine ([3H]EB) binds with an affinity of
100 pM to nAChRs in the pineal gland, and the density of these sites is
5 times that in rat cerebral cortex. The affinities of nicotinic drugs for binding sites in the pineal gland are similar to those at
3
4 nAChRs heterologously expressed in human embryonic kidney 293 cells. In functional studies, the potencies and efficacies of nicotinic drugs to activate or block whole-cell currents in dissociated pinealocytes match closely their potencies and efficacies to activate or block 86Rb+ efflux in the cells expressing heterologous
3
4 nAChRs. Measurements of mRNA indicated the presence of transcripts for
3,
2, and
4 nAChR subunits but not those for
2,
4,
5,
6,
7, or
3 subunits. Immunoprecipitation with subunit-specific antibodies showed that virtually all [3H]EB-labeled nAChRs contained
3 and
4 subunits associated in one complex. The
2 subunit was not associated with this complex. Taken together, these results indicate that virtually all of the nAChRs in the rat pineal gland are the
3
4 nAChR subtype and that the pineal gland can therefore serve as an excellent and convenient model in which to study the pharmacology and function of these receptors in a native tissue.
Address correspondence to: Dr. Kenneth J. Kellar, Department of Pharmacology, Georgetown University School of Medicine, Washington, DC 20057. E-mail: kellark{at}georgetown.edu
This article has been cited by other articles:
![]() |
D. C. Perry, D. Mao, A. B. Gold, J. M. McIntosh, J. C. Pezzullo, and K. J. Kellar Chronic Nicotine Differentially Regulates {alpha}6- and beta3-Containing Nicotinic Cholinergic Receptors in Rat Brain J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 306 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mao, R. P. Yasuda, H. Fan, B. B. Wolfe, and K. J. Kellar Heterogeneity of Nicotinic Cholinergic Receptors in Rat Superior Cervical and Nodose Ganglia Mol. Pharmacol., November 1, 2006; 70(5): 1693 - 1699. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Xu, M. M. Scott, and E. S. Deneris Shared Long-Range Regulatory Elements Coordinate Expression of a Gene Cluster Encoding Nicotinic Receptor Heteromeric Subtypes Mol. Cell. Biol., August 1, 2006; 26(15): 5636 - 5649. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ohtani, T. Oka, M. Badyuk, Y. Xiao, K. J. Kellar, and J. W. Daly Mouse beta-TC6 Insulinoma Cells: High Expression of Functional {alpha}3beta4 Nicotinic Receptors Mediating Membrane Potential, Intracellular Calcium, and Insulin Release Mol. Pharmacol., March 1, 2006; 69(3): 899 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Marritt, B. C. Cox, R. P. Yasuda, J. M. McIntosh, Y. Xiao, B. B. Wolfe, and K. J. Kellar Nicotinic Cholinergic Receptors in the Rat Retina: Simple and Mixed Heteromeric Subtypes Mol. Pharmacol., December 1, 2005; 68(6): 1656 - 1668. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Turner and K. J. Kellar Nicotinic Cholinergic Receptors in the Rat Cerebellum: Multiple Heteromeric Subtypes J. Neurosci., October 5, 2005; 25(40): 9258 - 9265. [Abstract] [Full Text] [PDF] |
||||